🇺🇸 FDA

Drug profile · INN

fluocinolone acetonide

RETISERT

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

fluocinolone acetonide (RETISERT) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.

Key facts

INN fluocinolone acetonide
Brand RETISERT
Route TOPICAL
Formulation IMPLANT

Frequently asked questions

What is fluocinolone acetonide?

fluocinolone acetonide (RETISERT) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.

What is the brand name for fluocinolone acetonide?

RETISERT is a marketed brand name for fluocinolone acetonide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of fluocinolone acetonide?

fluocinolone acetonide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.